Aurobindo Pharma reported INR196.67B in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Cipla INR 69.77B 366.6M Sep/2026
Divis Laboratories Ltd INR 27.07B 6.64B Sep/2026
Dr.Reddys Laboratories INR 154.3B 3.04B Sep/2026
Hindustan Unilever INR 192.95B 37.46B Sep/2026
Sun Pharmaceuticals INR 235.92B 9.7B Sep/2026
UPL INR 450.45B 102.97B Sep/2026